Literature DB >> 12165438

A novel monoclonal antibody screening method using the Luminex-100 microsphere system.

Jonathan Seideman1, David Peritt.   

Abstract

We describe the development of a robust and sensitive assay system (detection limit <500 pg/ml biotin-IL-6, K(d)=75 ng/ml), using Luminex-100 microspheres, that could effectively screen for neutralizing antibody whenever a soluble form of the receptor for a target molecule is available. As an example, we coupled a recombinant human interleukin-6 soluble receptor to a Luminex carboxylated microsphere and used a biotin-labeled recombinant human interleukin-6 as a probe to assess binding competition. Three anti-human IL-6 monoclonal antibodies that bind distinct IL-6 epitopes were used as test articles to evince the stringency of the screen. Our assay was able to detect antibody concentration as low as 10 ng/ml without interference from hybridoma growth medium or cell supernatant. The time-saving benefits of this assay format make it ideal for high-throughput screening (HTS) applications for neutralizing monoclonal antibodies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165438     DOI: 10.1016/s0022-1759(02)00168-0

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  Multiplex assay for simultaneous measurement of antibodies to multiple Plasmodium falciparum antigens.

Authors:  Genevieve G Fouda; Rose F G Leke; Carole Long; Pierre Druilhe; Ainong Zhou; Diane Wallace Taylor; Armead H Johnson
Journal:  Clin Vaccine Immunol       Date:  2006-10-11

2.  Enterobacter sakazakii enhances epithelial cell injury by inducing apoptosis in a rat model of necrotizing enterocolitis.

Authors:  Catherine J Hunter; Vijay K Singamsetty; Nikunj K Chokshi; Patricia Boyle; Victoria Camerini; Anatoly V Grishin; Jeffrey S Upperman; Henri R Ford; Nemani V Prasadarao
Journal:  J Infect Dis       Date:  2008-08-15       Impact factor: 5.226

3.  An antigen microarray immunoassay for multiplex screening of mouse monoclonal antibodies.

Authors:  Manlio Di Cristina; Luisa Nunziangeli; Maria Angela Giubilei; Barbara Capuccini; Lorenzo d'Episcopo; Giorgio Mazzoleni; Francesca Baldracchini; Roberta Spaccapelo; Andrea Crisanti
Journal:  Nat Protoc       Date:  2010-11-10       Impact factor: 13.491

4.  Facile generation of heat-stable antiviral and antitoxin single domain antibodies from a semisynthetic llama library.

Authors:  Ellen R Goldman; George P Anderson; Jinny L Liu; James B Delehanty; Laura J Sherwood; Lisa E Osborn; Larry B Cummins; Andrew Hayhurst
Journal:  Anal Chem       Date:  2006-12-15       Impact factor: 6.986

5.  Plasma cytokines can help to identify the development of severe acute pancreatitis on admission.

Authors:  Li-Hui Deng; Cheng Hu; Wen-Hao Cai; Wei-Wei Chen; Xiao-Xin Zhang; Na Shi; Wei Huang; Yun Ma; Tao Jin; Zi-Qi Lin; Kun Jiang; Jia Guo; Xiao-Nan Yang; Qing Xia
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

6.  Bone marrow mesenchymal stem cell-derived vascular endothelial growth factor attenuates cardiac apoptosis via regulation of cardiac miRNA-23a and miRNA-92a in a rat model of myocardial infarction.

Authors:  Yi-Sun Song; Hyun-Woo Joo; In-Hwa Park; Guang-Yin Shen; Yonggu Lee; Jeong Hun Shin; Hyuck Kim; Kyung-Soo Kim
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

7.  Naturally-acquired humoral immune responses against the N- and C-termini of the Plasmodium vivax MSP1 protein in endemic regions of Brazil and Papua New Guinea using a multiplex assay.

Authors:  Carmen Fernandez-Becerra; Sergi Sanz; Marina Brucet; Danielle I Stanisic; Fabiana P Alves; Erney P Camargo; Pedro L Alonso; Ivo Mueller; Hernando A del Portillo
Journal:  Malar J       Date:  2010-01-21       Impact factor: 2.979

8.  Evaluation of anti-IL-6 monoclonal antibody therapy using murine type II collagen-induced arthritis.

Authors:  Bailin Liang; Zheng Song; Bin Wu; Debra Gardner; David Shealy; Xiao-Yu Song; Paul H Wooley
Journal:  J Inflamm (Lond)       Date:  2009-04-15       Impact factor: 4.981

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.